Logo

GATC Teams with ETH Zurich on Food Safety Research

Jul 21, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GATC Biotech today said that it has partnered with the Institute of Food, Nutrition and Health at the Swiss Federal Institute of Technology (ETH Zurich) to develop a sequencing-based method for food quality assurance.

The partners said that they will perform their research using multiplatform sequencing including Pacific Biosciences' RS system, which GATC biotech recently purchased. They intend to develop a cost-efficient method for the taxonomic characterization of microbial communities in food.

Constanz, Germany-based GATC said that the so-called Metatxn Project is being funded with approximately €120,000 ($171,852) provided by the German Federal Ministry of Economics and Technology.

Filed under

Clinical Sequencing
Sequencing
Research Funding
research alliance
Next-Generation Sequencing
single-molecule sequencing
Pacific Biosciences
GATC Biotech
Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.